Clinical Trial Update: Safety and Efficacy Study of SHAPE Gel in Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of SHAPE Gel for alopecia areata is being conducted by TetraLogic Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• SHAPE Gel

Snippet

Sponsor: TetraLogic Pharmaceuticals | Conditions: Alopecia Areata | Phase 2 | Status: UNKNOWN